Found: 12
Select item for more details and to access through your institution.
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.820131
- By:
- Publication type:
- Article
Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.
- Published in:
- Scientific Reports, 2017, p. 46772, doi. 10.1038/srep46772
- By:
- Publication type:
- Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.
- Published in:
- Scientific Reports, 2017, p. 40920, doi. 10.1038/srep40920
- By:
- Publication type:
- Article
Correction: Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142246
- By:
- Publication type:
- Article
Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139236
- By:
- Publication type:
- Article
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 1, p. 1, doi. 10.1371/journal.pntd.0007072
- By:
- Publication type:
- Article
VIP plasma levels associate with survival in severe COVID‐19 patients, correlating with protective effects in SARS‐CoV‐2‐infected cells.
- Published in:
- Journal of Leukocyte Biology, 2022, v. 111, n. 5, p. 1107, doi. 10.1002/JLB.5COVA1121-626R
- By:
- Publication type:
- Article
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00428-w
- By:
- Publication type:
- Article
Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00428-w
- By:
- Publication type:
- Article
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 12, p. 1, doi. 10.1371/journal.ppat.1009127
- By:
- Publication type:
- Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article